Conference Description:

Despite the exciting advancements and investments accelerating the development of mRNA therapies, there is still limited regulatory guidance. Moreover, developing standardized and sensitive assays to assess quality and stability still remains a key challenge.

The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development, it will allow the field to develop a set of best practices to accelerate the movement of mRNA drugs through the clinic and to the patients. This meeting will showcase critical expertise and the latest assays developed by key industry players.

Join 60+ industry experts, including Moderna, Sanofi, Beam Therapeutics and more this December! Address key bottlenecks in the field and ensure your assay strategy is robust and reproducible to achieve regulatory compliance, therefore fast-tracking mRNA therapeutics and vaccines into the clinic and towards approval.


URL:
Tickets: https://go.evvnt.com/1915608-2?pid=154
Time: 8:00 AM - 4:00 PM

Prices:
Drug Developer Pricing - Conference Only: USD 2999.00,
Academic Pricing - Conference Only: USD 2599.00,
Vendor Pricing - Conference Only: USD 3699.00,
Drug Developer Pricing - Workshop Day Only: USD 2197.00,
Academic Pricing - Workshop Day Only: USD 1897.00,
Vendor - Workshop Day Only: USD 2497.00

Speakers: Alisa Zhilin-Roth, Scientist, Sanofi, Benjamin Hall, Senior Scientist, Tessera Therapeutics, Corey Perez, Principal Scientist - Discovery, Senda Biosciences, Craig Martin, Professor, University of Massachusetts Amherst, David Liston, Principal Scientist, ReCode Therapeutics, Dinesh Manvar, Associate Director, Analytical Development, Laronde, Harkewal Singh, Director, Head of Bioanalytics – Nonclinical Sciences, Moderna, Hui Wang, Senior Scientist, Bioanalytical/DMPK, mRNA Center of Excellence, Sanofi, Krishna Sapkota, Scientist, Beam Therapeutics, Li Li, Assistant Professor, University of Massachusetts Chan Medical School, Lusheng Fan, Investigator, Geneleap, Poulami Talukder, Principal Scientist, Tiba Biotech LLC, Rebecca Malott, Senior Scientist, Providence Therapeutics, Ryan Sowell, Director of Translational Discovery, Strand Therapeutics Inc., Shilpi Mahajan, Associate Director - Head of Bioanalytics, Switch Therapeutics, Taesun Eom, Associate Director in mRNA Science, Beam Therapeutics